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H-2 DETERMINANTS IN IRRADIATED F, HYBRID
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(From the Basel Institute for Immunology, CH-4058 Basel, Switzerland)
Radiation chimeras-irradiated animals injected with allogeneic hemopoietic
cells-often succumb eventually to graft-vs.-host (GVH)l disease (1). The
etiology ofthis condition, which is considered to be mediated byT lymphocytes,
is not clearly understood (2). In many situations it is probably caused by
immunocompetent T cells contaminating the donor cell population used.
Alternatively, the disease might reflect emergence of host-reactive T cells
differentiating from donor stem cells via the host thymus. In order to assess this
second possibility it is essential to know whether or not host-reactive T cells do
differentiate under such circumstances. The present study has examined this
question by studying the reactivity of lymphocytes from irradiated F, hybrid
mice injected several months previously with parental strain bone marrow cells
depleted of T cells. The results indicate that lymphocytes from such mice show
"split tolerance" towards host-type determinants, the cells responding to these
determinants in mixed leukocyte culture but failing to differentiate into
detectable cytotoxic lymphocytes.
Materials and Methods
Mice. CBA/J (H-2k, Mls°), CBA/H (H-2't, M18°), C3HJ (H-2R, Mls'), DBA/2 (H-2°, Mls'),
C57BL/6(H-2°, Mls°) (C57BL), SJL (H-2°),(CBA/J x DBA/2)F,,(CBA/J x C57BL)F, and(C3H/J x
SJL)F, mice were used and kept under conventional circumstances.
Cells. Thoracic duct lymphocytes (TDL) and cells from spleen, mesenteric lymph nodes and
bone marrow were obtained by standard techniques (3, 4) .
Preparation of Chimeras.
￿
Semiallogeneic radiation chimeras were prepared by injecting 2 x 107
viable (usually CBA/J) bone marrow cells intravenously into X-irradiated (900 R) 2-mo old (CBA x
DBA/2)F, or (CBA x C57BL)F, mice; to preventaGVH reaction themarrow cellswere treated with a
1:5 dilution of anti-B C3H antiserum andcomplement to remove T cells (5). With this regime it was
hoped to obtain healthy chimeras in which the hemopoietic system was derived entirely from the
donor stem cells. The mice received 100 mg/1 Neomycin (Medial, Geneva, Switzerland) and 10 mg/l
Polymyxin B (Nova, Copenhagen, Denmark) in their drinking water for 2 wk after irradiation. The
identity andproperties of lymphocytes from thechimeras were investigated 6mo afterirradiation, i.e.
at a stage when it was hoped the lymphoid system would be fully repopulated. For simplicity,
* Recipient of C. J. Martin Fellowship. Present address: Department of Zoology, University
College, WCIE 6BT, London.
'Abbreviations used in this paper: CML, cell-mediated lympholysis; GVH, graft-vs.-host; MLR,
mixedleukocyte reaction: TDL, thoracic duct lymphocytes.
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chimeras prepared by injecting CBA/J marrow cells into irradiated (CBA/J x DBA/2)F, mice will be
referred to as "CBA/J-.DBA/2 F," chimeras etc.
Alloantisera. Anti-CBA serum was obtained from DBA/2 mice hyperimmunized with CBA/J
spleen cells, anti-DBA/2 serum from C3H mice injected with BALB/c spleen cells and anti-B serum
from AKR mice given C3H thymus cells as described elsewhere (5) .
Testing Chimerism. An antihost-H-2 alloantiserum was used to detect the presence of host
cells in the chimeras. Cells were incubated with antiserum (1 :4 dilution) at 37°C followed by guinea
pig complement and cytotoxic indices calculated by dyeexclusion, using the method of Boyse et al.
(6) .
Mixed Leukocyte Reaction
MEASUREMENT IN vIvo.
￿
The system described by Sprent and Miller (7) was used. This method
involves transferring lymphoid cell populations lacking stem cells into irradiated (800 R) allogeneic or
semiallogeneic mice; the proliferative response (MLR) of the donor-strain T cells against the host
histocompatibility antigens at a required time is then assessed by measuring radioactivity in the
spleen within 1 h of an intravenous injection of tritiated thymidine ( [8H]TdR). In most experiments
this system was selected in favor of the more commonly used in vitro assay for three reasons: (a) The
in vivo assay was considered to closely approximate theenvironment encountered in the chimeras by
donor-derived T cells processed by the host thymus. (b) Thein vivo assay is quantitative, [3H]TdR
incorporation with limited numbers of cells being directly proportional to the number of T cells
injected (see Table II). (c) "Backstimulation" (8) of the donor cells by the host does notoccur; in this
respect, whereas parental strain cells can cause marked stimulation of F, cells in vitro (8) this does
not occur with the present system (see last line of Table II).
MEASUREMENT IN vrrRO. In some experiments MLR were measured in vitro using a standard
technique (9) in which 108 lymph node cells were cultured with 5 x 10, mitomycin-C -treated
stimulator cells in 1 ml tissue culture medium. Tritiated thymidine (Amersham, England [spec act 5
Ci/mmol]) was added after 96 h to the culture at 2 pCi/ml for 24 h before harvest. Levels of
radiolabeled DNA in the cells were then measured.
Cell-Mediated Lympholysis
WITH DBA/2 MASTOCYTOMA CELLS AS TARGETS. CBA/J lymphocytes were activated in vivo by
transferring them intravenously to irradiated (800 R) (CBA/J x DBA/2)F, mice. 6days later spleen
cells from the mice were incubated at 37°C in vitro at various ratios with 5 x 104 "Cr-labeled DBA/2
mastocytoma cells according to the method of Brunner et al. (10). Specific ''Cr release was
determined 6 h later.
WITH PHYTOHAEMAGGLUTIN-STIMULATED BLASTS AS TARGETS.
￿
Lymphocytes were activated in vitro
and assayed for cell-mediated lympholysis (CML) according to the method of Nabholz et al. (11).
Briefly, 1.5-2 x 10° viable spleen cells (responders) were cultured for 5 days in vitro with 8 x 108
mitomycin C-treated allogeneic spleen cells as stimulator cells. The cells were then resuspended to 1
ml and threefold serial dilutions were made. 100 ,u1 of the suspensions were incubated with 2 x 10'
"Cr-labeled, phytohemagglutin (PHA)-stimulated lymph node cells for 4 h at 37°C. The "Cr re-
leased into the supernate was then counted. Total releasable "Crwasdetermined by adding Zaponin
(Coulter Electronics Inc., Hialeah, Fla.) to the targets. Foreach incubation the % specific release was
calculated as:
100 x (% experimental release (ABM/CT) - % spontaneous release (CT)
100 - % spontaneous release (CT)
where A = responder, Bm = stimulator and CT = target cells.
Results
Health of Chimeras.
￿
The following chimeras were prepared : CBA/J,DBA/2
F,, CBA/J, C57BL F,, CBA/H, C57BL F,, and CM, SJL F,. With each
strain combination survival was excellent, 80-100% ofthe mice remaining in good
health for at least 6 mo. Random autopsies on mice killed between 1 and 6 moJ. SPRENT, H. VON BOEHMER, AND M. NABHOLZ
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revealed no signs of a GVH reaction in 18/20 mice. Two mice killed at 3 mo
postirradiation showed grossly enlarged spleens (three-four times normal size).
In over 25 mice killed at 6 mo postirradiation there was no evidence of a GVH
reaction .
Number and Identity of Recirculating Lymphocytes.
￿
Thoracic duct fistulas
were established in seven of the CBA/J, DBA/2 F, chimeras. TDL outputs
collected over 14-16 h are shown in Table I. With the exception of one mouse
(chimera 4) the outputs were similar to those found in normal CBA/J or (CBA/J
x DBA/2)F, mice . With specific antialloantisera no TDL of host origin could be
detected . Lymph node cells from two mice showed similar results (data not
shown). The proportion of 0-positive cells studied in three mice (74-81%) was
comparable to that in normal CBA/J mice. Collectively, these data indicated that
TABLE I
Number and Identity of TDL From Heavily Irradiated (CBA/J x DBA/2)F, Mice Injected
6 Mo Previously with CBA/J Bone Marrow Cells Treated with Anti-B Serum
* Established by dye exclusion (see Materials and Methods) .
$Mean of results of five-six mice per group.
the recirculating pool of T lymphocytes in the chimeras was fully repopulated
with cells of donor origin.
Response of Chimera Lymphocytes to Host-Type Determinants
MIXED-LEUKOCYTE REACTION .
￿
MLR were measured both in vivo and in vitro
(see Materials and Methods) . In the in vivo assay, when TDL from CBA/J,
DBA/2 F, chimeras were transferred to irradiated donor strain (CBA/J) mice,
[sH]TdR in corporation measured in the spleen at 5 days was not above the
"background" levels found in controls given [9H ]TdR but no lymphocytes (Table
II) . When the cells were exposed to the host antigens, however, i.e. by transfer to
DBA/2 or (CBA/J x DBA/2)F, mice, significant responses were obtained. These
responses were directly proportional to the number of cells injected (see data on
TDL from chimeras 1 and 5) . In all cases, however, they were less than the
Mice TDLoutputs
Period of
collection
Cytotoxic
Anti-
CBA/J
serum
index*
Anti-
DBA/2
serum
with:
Anti-
BC3H
serum
x 10-, h
Chimera1 110 16 100 2 -
Chimera2 90 16 98 2 -
Chimera3 67 14 100 0 74
Chimera4 35 14 99 2 81
Chimera5 110 14 100 1 79
Chimera6 58 14 100 0 -
Chimera7 75 14 99 0 -
Normal CBA/J 72$ 14 100 1 77
Normal (CBA/J x DBA/2)F, 90$ 14 100 99 -324
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TABLE II
Proliferative Response of Chimera TDL Transferred to Irradiated Mice of Various Strains
Exp.
[3H]TdR incorporation: cpm*
(x 10-3) in spleen
* Arithmetic mean of radioactivity in spleen measured at 5 days after intravenous transfer of TDL
and 45 min after intravenous injection of 25 1ACi ['H]TdR: four-five mice per group. Levels of
radioactivity obtained in irradiated mice given ['H]TdR but no lymphocytes have been subtracted
from the values shown; the values (x 10-') were 3.4 in CBA/J, 4.0 in DBA/2, 2.6 in (CBA/J x
DBA/2)F, and 3.6 in (CBA/J x C57BL)F, . The standard error of each group waswithin 5-10% of the
mean.
responses obtained with comparable numbers of TDL from normal CBA/J mice.
When a mixture of normal CBA/J TDL and TDL from chimera 1 were injected,
levels of [3H]TdR incorporation were similar to the sum of the values obtained
when the cells were injected separately. This suggested that the reduced response
of the chimera TDL was not explainable in terms of "suppressor" cells (12).
Transfer of the chimera TDL to (CBA/J x C57BL)F, mice showed that the cells
expressed normal or near normal reactivity to third party antigens (Table II).
TDL or lymph node cells were used to measure MLR's in vitro. An experiment
with a CBA/J,DBA/2 F, chimera is illustrated in Table III.As when assayed in
TDLtransferred
Normal CBA
No. of cells
4 x 105
CBA/J
0.4
DBA/2
21 .8
(CBA/J x
DBA/2)F,
(CBA/J x
C57BL)F,
2 x 105 - 12.0
Chimera 1 4 x 105 0.8 14.4
2 x 105 - 6.8
Normal CBA/J 2 x 105 - 19.6
+ chimera 1 2 x 105
Chimera2 4 x 105 1.1 11.8
Normal CBA/J 8 x 105 0.3 37.6 31.2 28.4
4 x 105 0.4 23 .5 22.4 16.9
2 x 105 - - 12.6 9.3
1 x 105 - - 5.0 4.2
Chimera3 8 x 105 0.2 8.6 6.0 26.1
Chimera4 8 x 105 0.1 4.0 3.7 31.3
Chimera5 8 x 105 0.3 13.2 7 .8 23.6
4x105 - - 4.4 11 .4
2 x 105 - - 2.2 5 .8
Normal DBA/2 8 x 105 - 0.9 - -
Normal (CBA/J x DBA/2)F, 8 x 105 - - 0.3 -
Normal (CBA/J x C57BL)F, 8 x 105 0.4 - - 0.2TABLE III
Proliferative Response of Chimera Lymphnode Cells in the In Vitro Mixed Leukocyte
Reaction to Various Stimulator Cells
Responder cells
1 x 10, ￿DBA/2
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Stimulator cells (5 x 106, mitomycin-C-treated)
(CBA/J x
￿
(CBA/J x
DBA/2)F, C57BL)F,
CBA/J
Chimera
￿
101.4 f8
￿
76.7 t4
￿
376.4 t7
￿
9.5 t1
CBA/J
￿
572.2 f 10
￿
560.7 t 32
￿
459.0 t 55
￿
16.8 t 0
Numbers represent arithmetic means of cpm x 10-' of triplicate cultures t standard deviation.
Counts for stimulator cells cultured alone were < 5 x 10- '
vivo it is evident that the chimera lymphocytes mounted a definite, though
reduced response against host-type determinants while responding normally to
third party determinants. Similar results were found with other CBA/J, DBA/2
F, chimeras and also with CBA/J, C57BL F, and C3H~ SJL F, chimeras (data
not shown).
CELL-MEDIATED LYMPHOLYSIS.
￿
To investigate whether the antihost MLR was
associated with the production of cytotoxic lymphocytes directed against CML
determinants, 107 TDL pooled from CBA/J~ DBA/2 F, chimeras 3-5 were
injected intravenously into each of five irradiated (CBA/J x DBA/2)F, mice.
Spleen cells from the recipients were pooled 6 days later and incubated in vitro
with 5'Cr-labeled DBA/2 mastocytoma cells. 5 'Cr release measured 6 h later was
no higher than when the target cells were incubated alone, even when high
lymphocyte: target cell ratios were used (Table IV) . This contrasted with control
experiments in which normal CBA/J TDL activated in vivo produced marked
target cell destruction. Table IV also shows that, compared to normal CBA/J
serum, serum from the chimeras did not significantly impair lysis.
The choice of DBA/2 mastocytoma cells as targets in the above experiment did
not allow study of CML to third party determinants. Therefore, to investigate the
specificity of the unresponsiveness in CML, additional experiments were
performed in which PHA-stimulated lymphocytes were used as targets. Spleen
cells from the chimeras were either tested directly on PHA-target cells or exposed
for 5 days to DBA/2 and C57BL determinants in vitro (see Materials and
Methods and legend to Fig. 1) and then incubated with ','Cr-labeled PHA-
stimulated cells derived from these strains. Fig. 1 shows the results of an
experiment with a CBA/J, DBA/2 F, chimera. It is evident that the chimera
cells failed to lyse target cells of host (DBA/2) origin but were effective against
third party (C57BL) determinants after 5 days of culture. Spleen cells from
normal CBA/J mice, by contrast, lysed both DBA/2 and C57BL targets though
not syngeneic cells. Five other experiments with these chimeras and also with
CBA/J,C57BL F, and C3H,SJL F, chimeras gave similar results: in three of
these experiments lymph node cells from the chimeras were tested in MLR and
shown to give a positive response against host-type determinants. Unresponsive-
ness to host-type determinants was also observed when (a) the in vitro exposure
to these determinants was reduced to 3 days and (b) with chimera cells tested
before culture (data not shown).326
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TABLE IV
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5 'Cr
released by
*Viable cells.
$Assayed essentially according to the method of Brunner et al. (14). Incubation was over 6 h.
§ 10' TDL were transferred intravenously to irradiated (800 R) mice and the spleens removed 6 days
later.
11 Pooled from chimeras 3 and 5.
1f Each figure represents arithmetic mean of three-four cultures. The standard errors were within 3%
of the mean.
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￿
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￿
Lysis of (a) C57BL targets and (b) DBA/2 targets by spleen cells from a CBA/J -.
DBA/2 F, chimera (0-") and a normal CBA/J mouse (O---O) activated in vitro by
(C57BL x DBA/2)F, cells. On the abscissae, the doses of killer cells incubated with the
(constant) number of target cells aregiven in terms of the numbers of respondercellsinitially
cultured, i.e. with respect to preactivation cell counts. Aliquots of chimera cells given in
brackets, normal CBA/J cells not in brackets. These ratios differ because thenumbers of cells
initially cultured (preactivation counts) were 2 x 10' forthe chimeracellsand 1.5 x 107forthe
normal CBA cells. Each point given in the figure represents the arithmetic mean of three
killer-target mixtures. Standard errors were within 2-3% of the mean. Lysis of syngeneic
(CBA/J) targets was nil with both populations (data not shown) . All targets were PHA blasts.
Test lymphocytes
Lymphocyte:
target cell
ratio*
Serum added
(dilution 1:6)
target cells
(DBA/2
masto-
cytoma)$
Spleen cellsfrom irradiated (CBA/J x 30:1 Normal CBA 70.17
DBA/2)F, mice injected with normal 30:1 Chimera° 67.0
CBA/J TDL§ 10:1 - 81.2
Spleen cellsfrom irradiated (CBA/J x 60:1 Normal CBA 16.4
DBA/2)F, mice injected with chimera 60:1 Chimera° 17.3
TDL§ 30:1 - 16.5
10:1 - 17.5
Target cells - 17.8
aloneSpecific blocking factors, produced by the chimera cells in culture, or
suppressor T cells might have accounted for the above results. To investigate this
possibility varying numbers of spleen cells from CBA/J, DBA/2 F, chimeras or
from normal (CBA/J x DBA/2)F, mice were cultured together with a constant
number (10') of normal CBA/J spleen cells and stimulated with (C57BL x
DBA/2)F, cells. After 5 days the killer activity of the various cultures on DBA/2
PHA blasts was tested. As indicated in Figs. 2 and 3 neither chimera cells nor
normal (CBA/J x DBA/2)F, cells inhibited the differentiation of normal CBA/J
cells into cells cytotoxic for the DBA/2 targets. Analogous experiments with
CBA/J, C57BL F, chimeras and C57BL targets gave similar results, irrespec-
tive ofwhether the period of cocultivation was for 3 or 5 days (data not shown) .
50-
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FIG. 2
￿
FIG. 3
FIG. 2.
￿
Lysis ofDBA/2 PHA targets by normal CBA/Jcells cocultivated in vitro with varying
numbersof CBA/J -. DBA/2F, chimera cells and stimulated by (C57BL x DBA/2)F, cells. On
the abscissae the doses ofCBAkiller cells incubated with the (constant) number of target cells
are given in terms of the numbersof CBA/J responder cells initially cultured. Each point given
in the figure represents the arithmetic mean of three cultures. ("-0), 15 x 108 chimera
spleen cells not cocultivated (i.e. cultured with stimulator cells only). (0---0), 15 x 108
CBA/J x DBA/2)F, cells not cocultivated;
￿
10 x 10° normal CBA/Jcells not cocul-
tivated; (O-O), 10 x 108 normal CBA/J + 5 x 108 chimera cells; (0-0), 10 x 10,
normal CBA/J + 10 x 108 chimera cells; (A-A), 10 x 108 normal CBA/J + 15 x 108
chimera cells.
FIG . 3.
￿
Lysis of DBA/2PHAtargets by normal CBA/J cells cocultivated in vitro with varying
numbersof normal (CBA/J x DBA/2)F, cells andstimulated by (C57BL x DBA/2)F, cells. On
the abscissae the doses ofCBA killer cells incubated with the (constant) number of target cells
are given in terms of numbers of CBA responder cells initially cultured. Each point given in the
figure represents the arithmetic mean of three cultures.
￿
10 x 108 normal CBA/J
cells notcocultivated; (O--0), 10 x 108 normal CBA/J cells + 5 x 108 (CBA/J x DBA/2)F,
cells; (0---0), 10 x 108 normal CBA/J cells + 10 x 108 (CBA/J x DBA/2)F, cells; (&-A),
10 x 108 normal CBA/J cells + 15 x 108 (CBA/J x DBA/2)F, cells.
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The experiment illustrated in Fig. 4 represents a more thorough attempt than
that in Table IV to investigate whether chimera serum contains "blocking"
activity. The serum was taken from a C3H,SJL F, chimera whose lymphocytes
had produced an antihost response in MLR but not in CML; the serum and
lymphocytes were taken at 6 mo postirradiation. It is evident from Fig. 4 that
when normal C3H cells were activated against SJL and DBA/2 determinants in
vitro, their capacity to lyse either SJL or DBA/2 targets was only slightly
inhibited when incubated in the presence of %5 (vol/vol) chimera serum. Normal
(C3H x SJL)F, serum, by contrast, caused marked inhibition.
W
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U
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a
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40-I
20-
a
FIG. 4. Lysis of DBA/2 (a) and SJL (b) PHA targets by C3H spleen cells stimulated in vitro
for 5days with both DBA/2 andSJL cells. During the killer assay the cells were incubated with
either no serum (0 - "), '/5 (vol/vol) of serum from aC3H -. SJLF, chimera (0-0), or V5
(vol/vol) of normal (C3H x SJL)F, serum (El--0) . Each point given in the culture
represents the arithmetic mean of three cultures.
Discussion
Attempts to obtain long-term survival of radiation chimeras made between H-
2-incompatible strains have usually (1, 2), though not invariably (18), been
unsuccessful, most mice dying within a few weeks. The studies presented here
indicate that, under the strict experimental conditions used, semiallogeneic
radiation chimeras totally repopulated with parental strain bone marrow cells
survive for a least 6 mo in apparent good health.
TDL outputs from the chimeras indicated that at 6 mo postirradiation the
recirculating pool of T lymphocytes was of normal size. Thus, quantitatively
speaking, there was no evidence that T-cell differentiation from stem cells was
impaired in a semiallogeneic environment.
Studies on the reactivity of lymphocytes from the chimeras showed that the
cells were responsive to host-type determinants in MLR, butnot in CML; against
third party antigens, by contrast, the cells responded well in both MLR and
CML. How can these findings be explained? Answering this question requires
consideration of the genetic control of the determinants involved in these
reactions. In the mouse, the CML determinants detected on PHA blasts are
considered to be coded for predominantly by the K and D regions of the H-2J . SPRENT, H. VON BOEHMER, AND M. NABHOLZ
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complex (13, 14). Stimuli for the MLR and GVH reaction, by contrast, are
believed to be controlled largely by the I region of the H-2 complex (14, 15);
MLR can also be elicited by (non-H-2)M locus differences (16). MLR determi-
nants have been referred to as "lymphocyte-defined" (13) since they seem to be
expressed predominantly by lymphohemopoietic cells. If so, then radiation
chimeras entirely repopulated with cells of donor origin would lack host-type
MLR determinants, and thus fail to stimulate an MLR by these cells; this is
supported by evidence that T cells of donor origin, unlike those of other origins,
fail to proliferate when transferred to reirradiated radiation chimeras (7). The
lack of MLR determinants would thus fail to eliminate (tolerize) cells reactive to
these determinants. It would follow, therefore, that donor-derived lymphocytes
differentiating in radiation chimeras would have the potential to respond to
host-type MLR determinants. Host-type CML determinants, by contrast, not
being restricted to lymphoid cells would exist in the chimeras and therefore be
available to confront CML-reactive cells. If induction of tolerance, e.g. by
deletion, followed such confrontation, lymphocytes reactive to host determinants
in CML, would be absent.
In interpreting the present findings in terms of this argument, three points
should be considered: (a) According to the above explanation, the antihost MLR
of the chimera lymphocytes should have been similar in magnitude to that of
normal donor-type T cells. The fact that it was considerably lower might be
explained in two ways. Firstly it could be argued that MLRdeterminants are not
restricted to lymphoid cells but are expressed to some extent by other cell types.
If so, host-type MLR determinants would be reduced in the chimeras but not
absent. The second possibility is that, in spite of the large dose of irradiation
used, a few host-type lymphohemopoietic cells survived, i.e. in numbers
sufficient to stimulate (and tolerize) the donor cells but too small to be detected
by the dye exclusion technique used for cell identification. At present, it is
impossible to distinguish between these two possibilities. (b) An obvious
prediction is that in chimeras containing a mixture of donor-derived and
host-derived (or host-type) lymphohemopoietic cells, the donor-derived lympho-
cytes would lack the potential to mount an anti-host MLR. This has been found
to be the case in two situations, firstly in chimeras prepared after sublethal
irradiation (unpublished data) and secondly in lethally irradiated mice injected
with hemopoietic cells from both parent-tetraparental chimeras (17). (c) Other
workers have reported that radiation chimeras contain blocking serum factors
demonstrable in a microcytotoxicity assay (18). Such factors, or suppressor T
cells, might have accounted for the unresponsiveness in CML observed in the
present study. This possibility was investigated by determining (i) whether
serum from the chimeras could specifically inhibit CML ofnormal donor-strain
cytotoxic lymphocytes and (ii) if addition of chimera lymphocytes to normal
donor-type lymphocytes would prevent the latter from differentiating into
cytotoxic lymphocytes. In neither situation was there any evidence of specific
inhibition. It would seem likely therefore that the unresponsiveness observed in
CML reflected deletion of the reactive cells rather than suppression.
Whatever the interpretation, the present findings, together with those on
tetraparental radiation chimeras [which live for prolonged periods in good health330
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(17)], indicate that the differentiation of stem cells to competent T cells in a
semiallogeneic environment does not have a deleterious effect on the host. Thus
it would seem that whereas harmful side effects follow confrontation of
competent T cells with alloantigens, T cells encountering such antigens during
differentiation from stem cells are eliminated with no injurious sequelae. The
problem of preparing healthy chimeras would therefore seem to lie mainly with
effective removal of competent T cells from the stem cell population used.
As a whole, the present findings provide direct support forthe proposal ofBach
et al. (19) that lymphocytes reactive in MLR and in CML have different
specificities. Whether this also applies to cells involved in graft rejection, GVH
reactions and alloantibody production is currently being investigated with the
system described here.
Summary
Semiallogeneic radiation chimeras were prepared by injecting heavily irradi-
ated F, hybrid mice with bone marrow cells from one parental strain ; the bone
marrow cells were treated with anti-B serum and complement to remove T cells
and injected in large numbers (2 x 107 cells) . The mice survived in excellent
health until sacrifice 6 mo later. Thoracic duct cannulation at this stage showed
that the mice possessed normal numbers of recirculating lymphocytes. Close to
100% of thoracic duct lymphocytes and lymph node cells were shown to be of
donor strain origin.
The capacity of lymphocytes from the chimeras to respond to host-type
determinants was tested in mixed leukocyte culture and in an assay for
cell-mediated lympholysis (CML). Mixed leukocyte reactions (MLR) were
measured both in vitro and in vivo; tumor cells and phytohemagglutinin-
stimulated blast cells were used as target cells for measuring CML. While
responding normally to third party determinants, cells from the chimeras gave a
definite, though reduced MLR when exposed to host-type determinants. How-
ever, this proliferative response to host-type determinants, unlike that to third
party determinants, was not associated with differentiation into cytotoxic
lymphocytes. No evidence could be found that unresponsiveness in this situa-
tion was due to blocking serum factors or suppressor T cells. It is argued that the
results support the concept that lymphocytes responsive in mixed leukocyte
culture have a different specificity to those exerting cell-mediated lympholysis.
The technical assistance ofMisses P. Youngand N. Erhardt is gratefully acknowledged.
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